- 询价
- MedChemExpress(MCE)
- 美国
- HY-153490
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Please store the product under the recommended conditions in the Certificate of Analysis.
- 英文名：
CGP 69846A; ISIS 9271
- 库存：
货期：询盘
- 供应商：
MedChemExpress LLC
- CAS号：
177075-18-2
- 规格：
询盘
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
ISIS 5132
CAS No. : 177075-18-2
MCE 国际站：ISIS 5132
产品活性：ISIS 5132是一种特异性下调 c-raf 表达的寡核苷酸。
研究领域：MAPK/ERK Pathway
作用靶点：Raf
相关产品：Sorafenib | Dabrafenib | Vemurafenib | Regorafenib | Doramapimod | Encorafenib | SB-590885 | PLX-4720 | Belvarafenib | GDC-0879 | LY3009120 | AZ 628 | Avutometinib | GW 5074 | LXH254 | Tovorafenib | Exarafenib | TAK-632 | Lifirafenib | Agerafenib | RAF265 | CCT196969 | Rineterkib | ZM 336372 | BI-882370
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Antisense Therapeutics: A Promise Waiting to Be Fulfilled
During the past decade, only one antisense-based therapy has received full Food and Drug Administration (FDA) approval. Vitravene™, developed by Isis Pharmaceuticals, was the first drug based on antisense technology to be successfully
Using Oligonucleotide Scanning Arrays to Find Effective Antisense Reagents
by abnormal or unwanted expression of a gene, such as cancers. The first antisense oligonucleotide-based drug (Vitravene™: ISIS Pharmaceuticals) was introduced in 1998 to treat cytomegalovirus (CMV) retinitis in AIDS patients: several others are in advanced
and suitable reactants) for lead idea generation, lead hopping, and library design. There had been an intense focus on ease of use, good performance and robustness, and synergy with existing desktop tools such as ISIS/Draw and SpotFire. In this chapter
技术资料暂无技术资料 索取技术资料
